Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IITerminatedD-0913-2023

Drug recall · July 19, 2023

Sunitinib Malate Capsules recall

Why: Failed Moisture Limits: Water (moisture) content above the approved product specifications.

Class II: could cause temporary or reversible health problems; serious harm is remote.

The recall

Product

Sunitinib Malate Capsules, 12.5 mg, 28-count bottles, Rx only, Manufactured By: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054, NDC 0093-8199-28

Lots / codes

Lot # 100037220, Exp 10/2024

Quantity
180 bottles
Company
Teva Pharmaceuticals USA Inc, Parsippany, NJ
Distribution
Product was distributed to 3 wholesalers/distributors who further distributed the product Nationwide in the USA.
Initiated
July 5, 2023 · Voluntary: Firm initiated
Classified
July 11, 2023
Reported
July 19, 2023
Ended
January 10, 2024
How notified
Letter

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.